tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN
US Market
REGN
Regeneron
RESEARCH TOOLSreports
Want to see REGN full AI Analyst Report?

Regeneron (REGN) Stock News & Sentiment

5,210 Followers
Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
Premium
Weekend Updates
Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
2d ago
PBA
BURL
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
Premium
Company Announcements
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
3d ago
REGN
Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension
Premium
Company Announcements
Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension
5d ago
REGN
Regeneron: Buy Rating and $968 Price Target Reaffirmed Despite Fi Anlimab Setback, Backed by Robust Pipeline and IP Extensions
Premium
Ratings
Regeneron: Buy Rating and $968 Price Target Reaffirmed Despite Fi Anlimab Setback, Backed by Robust Pipeline and IP Extensions
7d ago
REGN
Regeneron: Buy Rating Reiterated as Analyst Trims Target to $730 but Sees Long-Term Upside from Core Franchise and Pipeline
Premium
Ratings
Regeneron: Buy Rating Reiterated as Analyst Trims Target to $730 but Sees Long-Term Upside from Core Franchise and Pipeline
7d ago
REGN
Regeneron Buy Rating Reiterated as Analyst Keeps $860 Price Target After LAG-3 Setback
Premium
Ratings
Regeneron Buy Rating Reiterated as Analyst Keeps $860 Price Target After LAG-3 Setback
8d ago
REGN
The Week That Was, The Week Ahead: Macro and Markets, May 17
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, May 17
8d ago
V
AA
More REGN News >

REGN News on the Web

Stocks making big moves this week: Toll Brothers, Booz Allen Hamilton, Strategy, Regeneron, and Micron
stockstory
Bearish
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Question
stockstory
Bearish
Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
TipRanks News
Bearish
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
TipRanks News
Bullish
Regeneron Reports Positive Phase 1/2 LINKER-AL2 Data For Lynozyfic In Treating Amyloidosis
rttnews
Bullish
Regeneron Pharmaceuticals's Genetic Hearing Loss Drug Wins EMA Filing Acceptance
rttnews
Bullish
Regeneron says EMA accepted review under AA the MAA for Otarmeni
TipRanks News
Bullish
Regeneron Reports Positive Results For Lynozyfic In AL Amyloidosis Trial
rttnews
Bullish

News Score - Last 7 Days

Positive
REGN
Sector Average
Media Buzz
This Week13 articles
Weekly Average25.25 articles
News Sentiment
This Week79%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?
13 articles about REGN were published this week. In an average week, 25.25 articles are published.
    What is REGN’s weekly average amount of articles?
    In an average week, 25.25 articles about REGN are published.
      What is REGN’s News Sentiment?
      79% of articles about REGN were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week